Home / 2015 (page 98)

Yearly Archives: 2015

Effects of Lifestyle Intervention and Metformin on the Development of Type 2 in Women With or Without GDM

Women with a history of GDM had 48% increased risk of developing diabetes… From previous studies it is known that women with gestational diabetes are at a higher risk for the development of type 2 diabetes. Previous results from the Diabetes Prevention Program (DPP) showed that Intensive Lifestyle Intervention (ILS) …

Read More »

Are Lower Urinary Tract Symptoms Linked to Incidence of Type 2 Diabetes and Heart Disease?

Occurrence of lower urinary tract symptoms might be a useful predictor… There has been increasing evidence suggesting an association of cardiovascular and metabolic risk factors with Lower Urinary Tract Symptoms (LUTS). An increased likelihood of LUTS with decreased physical activity and increased obesity has been reported in studies. An association …

Read More »

Type 2 Diabetes Linked to Low Vitamin D Levels

Low serum vitamin D levels are more closely associated with diabetes than obesity is, claim Spanish researchers, who go on to suggest that vitamin D deficiency may be linked to an increased risk for type 2 diabetes. They found that serum 25-hydroxy vitamin D levels are reduced in prediabetic and …

Read More »

Squid ID

Colorful dog tags that connect to a patient’s online medical information when either the QR barcode is scanned with a mobile device or the URL printed on the back is accessed. Emergency contacts are also optionally alerted by text and email. Cost of subscription is included with purchase of Squid …

Read More »

Letter from the Editor, #772

Thirty grams of protein seems to be the magic number for breakfast as seen in this week’s Item #1, when we are talking about improving glucose levels and weight. This study goes along with others that point to to the need for high protein breakfasts for all our patients. Four …

Read More »

GLP-1 Analogs Special Edition, March 2015

We are rapidly approaching the ten year anniversary of the entrance of GLP-1 analogs into the diabetes marketplace. It all started with exenatide and most medical professionals we interviewed back then did not believe that clinicians or patients would use an injectable unless they had to. Fast forward ten years …

Read More »